Kesoram Industries Ltd. - Research Center
502937 KESORAMIND Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 1,842.62 | 1,608.14 | 1,901.86 | 1,637.70 | 1,025.65 |
| Operating profit | 192.63 | 98.15 | 228.63 | 320.02 | 26.44 |
| Interest | 220.76 | 206.96 | 241.47 | 240.23 | 159.51 |
| Gross profit | -4.39 | -69.27 | 6.47 | 98.63 | -85.78 |
| EPS (Rs) | -1.36 | -2.66 | -6.02 | 1.04 | -36.39 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 23.74 | 39.54 | 19.31 | 18.84 | 47.29 |
| Stock adjustment | 0.39 | -11.97 | 39.47 | -58.65 | 30.12 |
| Raw material | 201.85 | 177.59 | 188.46 | 172.60 | 116.89 |
| Power and fuel | - | - | 329.93 | - | 280.05 |
| Employee expenses | 76.16 | 77.78 | 76.15 | 72.17 | 60.70 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,371.59 | 1,266.59 | 1,039.22 | 1,131.56 | 511.45 |
| Provisions made | - | - | - | - | - |
| Depreciation | 53.32 | 41.70 | 45.72 | 45.01 | 45.92 |
| Taxation | -15.32 | -28.43 | -26.10 | 16.23 | - |
| Net profit / loss | -42.39 | -82.54 | -147.15 | 17.14 | -518.82 |
| Extra ordinary item | - | - | -134.00 | -20.25 | -387.12 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 310.66 | 310.66 | 244.41 | 164.81 | 142.59 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.45 | 6.10 | 12.02 | 19.54 | 2.58 |
| GPM (%) | -.24 | -4.20 | .34 | 5.95 | -7.99 |
| NPM (%) | -2.27 | -5.01 | -7.66 | 1.03 | -48.35 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis